Published in PLoS One on June 25, 2012
New insight into Ki67 expression at the invasive front in breast cancer. PLoS One (2013) 1.00
S6K2: The Neglected S6 Kinase Family Member. Front Oncol (2013) 0.92
Progranulin promotes colorectal cancer proliferation and angiogenesis through TNFR2/Akt and ERK signaling pathways. Am J Cancer Res (2015) 0.81
Potential roles of microglial cell progranulin in HIV-associated CNS pathologies and neurocognitive impairment. J Neuroimmune Pharmacol (2014) 0.79
The role of progranulin in diabetes and kidney disease. Diabetol Metab Syndr (2015) 0.79
Progranulin is a novel independent predictor of disease progression and overall survival in chronic lymphocytic leukemia. PLoS One (2013) 0.78
The role of PGRN in musculoskeletal development and disease. Front Biosci (Landmark Ed) (2014) 0.77
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet (2005) 42.90
The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science (2011) 4.76
Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J Mol Med (Berl) (2003) 3.65
Mechanisms of tamoxifen resistance. Endocr Relat Cancer (2004) 2.92
Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism. Gut (2011) 1.91
Isolation and sequence of the granulin precursor cDNA from human bone marrow reveals tandem cysteine-rich granulin domains. Proc Natl Acad Sci U S A (1992) 1.74
Progranulin is a potential prognostic biomarker in advanced epithelial ovarian cancers. Gynecol Oncol (2010) 1.61
Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes. Eur J Cancer (2007) 1.46
Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma. Hepatology (2008) 1.44
Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue. Diabetes (2008) 1.42
Consistency of staining and reporting of oestrogen receptor immunocytochemistry within the European Union--an inter-laboratory study. Virchows Arch (2004) 1.19
PC cell-derived growth factor mediates tamoxifen resistance and promotes tumor growth of human breast cancer cells. Cancer Res (2004) 1.13
HDL/apolipoprotein A-I binds to macrophage-derived progranulin and suppresses its conversion into proinflammatory granulins. J Atheroscler Thromb (2010) 1.09
Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study. Breast Cancer Res (2011) 1.08
Molecular and pharmacological aspects of antiestrogen resistance. J Steroid Biochem Mol Biol (2001) 1.06
Effective tamoxifen therapy of breast cancer involves both antiproliferative and pro-apoptotic changes. Eur J Cancer (2000) 1.04
Optimizing endocrine therapy for breast cancer. J Clin Oncol (2005) 1.03
Increased Circulating Level of the Survival Factor GP88 (Progranulin) in the Serum of Breast Cancer Patients When Compared to Healthy Subjects. Breast Cancer (Auckl) (2011) 0.97
GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cells. BMC Cancer (2011) 0.94
PC cell-derived growth factor stimulates proliferation and confers Trastuzumab resistance to Her-2-overexpressing breast cancer cells. Clin Cancer Res (2006) 0.93
Progranulin overexpression predicts overall survival in patients with glioblastoma. Med Oncol (2011) 0.90
Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer. N Engl J Med (2015) 6.38
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. N Engl J Med (2015) 4.97
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study. Lancet Oncol (2013) 3.87
Clinical implications of CYP2D6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancer. J Clin Oncol (2007) 2.71
The metabolic syndrome and associated lifestyle factors among South Korean adults. Int J Epidemiol (2004) 2.24
Micropapillary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance. Am J Surg Pathol (2002) 2.15
Breast cancer subtypes and survival in patients with brain metastases. Breast Cancer Res (2008) 1.95
Alcohol consumption and the metabolic syndrome in Korean adults: the 1998 Korean National Health and Nutrition Examination Survey. Am J Clin Nutr (2004) 1.93
High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome. Endocr J (2013) 1.77
Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer. Breast Cancer Res Treat (2007) 1.68
Anti-Obesity Drugs: A Review about Their Effects and Safety. Diabetes Metab J (2012) 1.66
Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab (2003) 1.61
Randomized phase III trial of ixabepilone plus capecitabine versus capecitabine in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. J Clin Oncol (2010) 1.59
Extranodal follicular dendritic cell sarcoma of the head and neck region: three new cases, with a review of the literature. Mod Pathol (2002) 1.56
Association of a vascular endothelial growth factor gene 936 C/T polymorphism with breast cancer risk: a meta-analysis. Breast Cancer Res Treat (2010) 1.50
Evaluation of plasma leptin levels & BMI as predictor of postpartum weight retention. Indian J Med Res (2008) 1.47
Concordant HER2 status between metastatic breast cancer cells in CSF and primary breast cancer tissue. Breast Cancer Res Treat (2009) 1.45
Socioeconomic status in relation to obesity and abdominal obesity in Korean adults: a focus on sex differences. Obesity (Silver Spring) (2006) 1.43
The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen. Oncogene (2004) 1.38
Primary primitive neuroectodermal tumor of the breast: a case report. Korean J Radiol (2009) 1.34
Web-based tailored education program for disease-free cancer survivors with cancer-related fatigue: a randomized controlled trial. J Clin Oncol (2012) 1.34
Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer. Breast Cancer Res Treat (2010) 1.30
Impact of breast cancer diagnosis and treatment on work-related life and factors affecting them. Breast Cancer Res Treat (2008) 1.24
Population-based breast cancer statistics in Korea during 1993-2002: incidence, mortality, and survival. J Korean Med Sci (2007) 1.23
Depressive mood and abdominal fat distribution in overweight premenopausal women. Obes Res (2005) 1.22
Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area. Clin Endocrinol (Oxf) (2006) 1.20
Exendin-4 improves steatohepatitis by increasing Sirt1 expression in high-fat diet-induced obese C57BL/6J mice. PLoS One (2012) 1.18
Association between adiponectin levels and coronary heart disease and mortality: a systematic review and meta-analysis. Int J Epidemiol (2013) 1.14
Single nucleotide polymorphisms of CYP19A1 predict clinical outcomes and adverse events associated with letrozole in patients with metastatic breast cancer. Cancer Chemother Pharmacol (2011) 1.13
Metaplastic breast cancer: clinicopathological features and its prognosis. J Clin Pathol (2012) 1.13
Activation of peroxisome proliferator-activated receptor gamma by rosiglitazone increases sirt6 expression and ameliorates hepatic steatosis in rats. PLoS One (2011) 1.13
Central obesity as a risk factor for prostatic hyperplasia. Obesity (Silver Spring) (2006) 1.12
1,5-Anhydroglucitol reflects postprandial hyperglycemia and a decreased insulinogenic index, even in subjects with prediabetes and well-controlled type 2 diabetes. Diabetes Res Clin Pract (2009) 1.12
Cost-effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC). Breast Cancer Res Treat (2008) 1.12
Novel genetic variations associated with salt sensitivity in the Korean population. Hypertens Res (2011) 1.11
Prognostic Implications of MicroRNA-21 Overexpression in Invasive Ductal Carcinomas of the Breast. J Breast Cancer (2011) 1.10
1,5-Anhydroglucitol in diabetes mellitus. Endocrine (2012) 1.10
Extent of routine central lymph node dissection with small papillary thyroid carcinoma. World J Surg (2007) 1.08
Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study. Breast Cancer Res (2011) 1.08
Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer. Am J Clin Oncol (2013) 1.07
Cigarette smoking increases abdominal and visceral obesity but not overall fatness: an observational study. PLoS One (2012) 1.06
Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability. BMC Cancer (2008) 1.06
Mechanisms of adipose tissue redistribution with rosiglitazone treatment in various adipose depots. Metabolism (2009) 1.06
Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival. Breast Cancer Res Treat (2010) 1.05
Locoregional recurrence of breast cancer in patients treated with breast conservation surgery and radiotherapy following neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys (2010) 1.05
Jnk signaling pathway-mediated regulation of Stat3 activation is linked to the development of doxorubicin resistance in cancer cell lines. Biochem Pharmacol (2009) 1.04
A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer. Breast Cancer Res Treat (2007) 1.04
Predicting tissue HER2 status using serum HER2 levels in patients with metastatic breast cancer. Clin Chem (2006) 1.04
Salinomycin, a p-glycoprotein inhibitor, sensitizes radiation-treated cancer cells by increasing DNA damage and inducing G2 arrest. Invest New Drugs (2011) 1.03
Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients. Breast Cancer Res Treat (2006) 1.02
Serum gamma-glutamyl transferase activity predicts future development of metabolic syndrome defined by 2 different criteria. Clin Chim Acta (2009) 1.01
Waist circumference thresholds provide an accurate and widely applicable method for the discrimination of diabetes. Diabetes Care (2007) 1.01
Dietary preference, physical activity, and cancer risk in men: national health insurance corporation study. BMC Cancer (2008) 1.00
Tamoxifen-resistant breast cancers show less frequent methylation of the estrogen receptor beta but not the estrogen receptor alpha gene. J Mol Med (Berl) (2004) 1.00
In vivo MR imaging of tissue-engineered human mesenchymal stem cells transplanted to mouse: a preliminary study. Ann Biomed Eng (2006) 1.00
Circulating numbers of endothelial progenitor cells in patients with gastric and breast cancer. Cancer Lett (2003) 0.99
Prognostic Impact of [18F] FDG-PET in operable breast cancer treated with neoadjuvant chemotherapy. Ann Surg Oncol (2009) 0.99
Incidental ovarian 18F-FDG accumulation on PET: correlation with the menstrual cycle. Eur J Nucl Med Mol Imaging (2005) 0.98
Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer. Breast Cancer Res Treat (2008) 0.98
High volumetric breast density predicts risk for breast cancer in postmenopausal, but not premenopausal, Korean Women. Ann Surg Oncol (2014) 0.97
Impact of awareness of terminal illness and use of palliative care or intensive care unit on the survival of terminally ill patients with cancer: prospective cohort study. J Clin Oncol (2011) 0.97
Breast cancer diagnosis using a microfluidic multiplexed immunohistochemistry platform. PLoS One (2010) 0.97
The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease. J Gastroenterol Hepatol (2008) 0.96
Salinomycin sensitizes antimitotic drugs-treated cancer cells by increasing apoptosis via the prevention of G2 arrest. Biochem Biophys Res Commun (2012) 0.96
The relationship of adiponectin/leptin ratio with homeostasis model assessment insulin resistance index and metabolic syndrome in apparently healthy korean male adults. Korean Diabetes J (2010) 0.96
Fatty fish and fish omega-3 fatty acid intakes decrease the breast cancer risk: a case-control study. BMC Cancer (2009) 0.96
BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations. Cancer Lett (2006) 0.96
Higher serum free thyroxine levels are associated with coronary artery disease. Endocr J (2008) 0.95
Age, body mass index, current smoking history, and serum insulin-like growth factor-I levels associated with bone mineral density in middle-aged Korean men. J Bone Miner Metab (2004) 0.95
Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients. Breast Cancer Res Treat (2013) 0.95
Dairy product intake is inversely associated with metabolic syndrome in Korean adults: Anseong and Ansan cohort of the Korean Genome and Epidemiology Study. J Korean Med Sci (2013) 0.94
Serum 1,5-anhydroglucitol concentrations are a reliable index of glycemic control in type 2 diabetes with mild or moderate renal dysfunction. Diabetes Care (2011) 0.93
A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+ advanced breast cancer. Eur J Cancer (2013) 0.92
High serum TGF-α predicts poor response to lapatinib and capecitabine in HER2-positive breast cancer. Breast Cancer Res Treat (2010) 0.92
Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002-2013: Nationwide population-based cohort study. Medicine (Baltimore) (2016) 0.92
Effect on Glycemic, Blood Pressure, and Lipid Control according to Education Types. Diabetes Metab J (2011) 0.91
Association between serum vaspin concentrations and visceral adipose tissue in Korean subjects. Metabolism (2010) 0.91
Retrospective analysis on the efficacy, safety and treatment failure group of sitagliptin for mean 10-month duration. Diabetes Metab J (2011) 0.91
High urinary ACE2 concentrations are associated with severity of glucose intolerance and microalbuminuria. Eur J Endocrinol (2013) 0.91
Decreased identification rate of sentinel lymph node after neoadjuvant chemotherapy. World J Surg (2004) 0.91
Serum adipocyte-specific fatty acid-binding protein is associated with nonalcoholic fatty liver disease in apparently healthy subjects. J Nutr Biochem (2010) 0.90
Exendin-4 attenuates endoplasmic reticulum stress through a SIRT1-dependent mechanism. Cell Stress Chaperones (2014) 0.90
Lack of any association between functionally significant CYP2D6 polymorphisms and clinical outcomes in early breast cancer patients receiving adjuvant tamoxifen treatment. Breast Cancer Res Treat (2011) 0.90
The association between regional arterial stiffness and diabetic retinopathy in type 2 diabetes. Atherosclerosis (2012) 0.90
Status and prospect of workforce requirement for surgery in republic of Korea. J Korean Surg Soc (2011) 0.90
Primary malignant teratoma with a primitive neuroectodermal tumor component in thyroid gland: a case report. J Korean Med Sci (2007) 0.89
Outcomes of positron emission tomography-staged clinical N3 breast cancer treated with neoadjuvant chemotherapy, surgery, and radiotherapy. Int J Radiat Oncol Biol Phys (2011) 0.89
Dietary mushroom intake and the risk of breast cancer based on hormone receptor status. Nutr Cancer (2010) 0.89